Curated gurus reporting this holding
A curated subset of well-known investors — not the full institutional ownership.
- Duquesne Family Office238,600주2026-06-30 · 증감 0주
$36.57-2.66%
2026-10-06 closeXenon Pharmaceuticals's company information is shown as of 2026-10-06. It is a security listed on Nasdaq, ticker XENE. There are 14 published related companies.
About this company
Xenon Pharmaceuticals last closed at $36.57 (-2.66%) on 2026-10-06. Listed on Nasdaq.
Who held it · filings
Filed recordA historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F is quarterly and may be filed up to 45 days later.
Suppliers, competitors and related stocks
- Vertex PharmaceuticalsCompetitor
희귀질환·통증 치료제 개발 경쟁사
- Sage TherapeuticsCompetitor
중추신경계(CNS) 신약 개발 경쟁사
- EisaiCustomer
Xenon 파이프라인 공동개발·상업화 파트너 성격
- Neurocrine BiosciencesCompetitor
신경계 질환 치료제 영역 경쟁사
- Bristol Myers SquibbCompetitor
정신질환·신경과학 파이프라인 경쟁사
- AbbVieCompetitor
신경과학 및 희귀질환 약물 개발 경쟁사
- Johnson & JohnsonCompetitor
신경과학·면역질환 등 대형 제약 경쟁사
- PfizerCompetitor
중추신경계 및 희귀질환 신약 경쟁사
- NovartisCompetitor
희귀질환·신경과학 분야 글로벌 경쟁사
- Eli LillyCompetitor
신경과학·통증 및 대형 제약 R&D 경쟁사
- BiogenCompetitor
CNS·신경질환 치료제 개발 경쟁사
- Acadia PharmaceuticalsCompetitor
신경정신과 질환 치료제 경쟁사
- Ionis PharmaceuticalsCompetitor
RNA 기반 신약 플랫폼·희귀질환 경쟁사
- SanofiCompetitor
희귀질환·신경과학 분야 글로벌 경쟁사
📦 ETFs holding this stock
by weight · top-10 constituents basisPassive money holding this stock ≈ $8M(lower bound — top-10 basis, not a forecast)
Factual holdings info from daily disclosures — not a recommendation.
Look up another stock →Quantus Signal · live data · not investment advice · Privacy Policy